133 related articles for article (PubMed ID: 10693234)
1. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction.
Pera M
Recent Results Cancer Res; 2000; 155():1-14. PubMed ID: 10693234
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance.
Cook MB; Thrift AP
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):1-26. PubMed ID: 33213789
[TBL] [Abstract][Full Text] [Related]
3. Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction.
Chak A; Falk G; Grady WM; Kinnard M; Elston R; Mittal S; King JF; Willis JE; Kondru A; Brock W; Barnholtz-Sloan J
Am J Gastroenterol; 2009 Aug; 104(8):1913-21. PubMed ID: 19491834
[TBL] [Abstract][Full Text] [Related]
4. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.
Levine DM; Ek WE; Zhang R; Liu X; Onstad L; Sather C; Lao-Sirieix P; Gammon MD; Corley DA; Shaheen NJ; Bird NC; Hardie LJ; Murray LJ; Reid BJ; Chow WH; Risch HA; Nyrén O; Ye W; Liu G; Romero Y; Bernstein L; Wu AH; Casson AG; Chanock SJ; Harrington P; Caldas I; Debiram-Beecham I; Caldas C; Hayward NK; Pharoah PD; Fitzgerald RC; Macgregor S; Whiteman DC; Vaughan TL
Nat Genet; 2013 Dec; 45(12):1487-93. PubMed ID: 24121790
[TBL] [Abstract][Full Text] [Related]
5. Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma.
Agarwal S; Bell MG; Dhaliwal L; Codipilly DC; Dierkhising RA; Lansing R; Gibbons EE; Leggett CL; Kisiel JB; Iyer PG
Dig Dis Sci; 2024 Jan; 69(1):246-253. PubMed ID: 37914889
[TBL] [Abstract][Full Text] [Related]
6. Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study.
Imamura Y; Watanabe M; Oki E; Morita M; Baba H
Ann Gastroenterol Surg; 2021 Jan; 5(1):46-59. PubMed ID: 33532680
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Barrett esophagus in first-degree relatives of patients with esophageal adenocarcinoma.
Juhasz A; Mittal SK; Lee TH; Deng C; Chak A; Lynch HT
J Clin Gastroenterol; 2011; 45(10):867-71. PubMed ID: 21617543
[TBL] [Abstract][Full Text] [Related]
8. AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas.
Ghosh P; Campos VJ; Vo DT; Guccione C; Goheen-Holland V; Tindle C; Mazzini GS; He Y; Alexandrov LB; Lippman SM; Gurski RR; Das S; Yadlapati R; Curtius K; Sahoo D
JCI Insight; 2022 Sep; 7(18):. PubMed ID: 36134663
[TBL] [Abstract][Full Text] [Related]
9. Navigating the complexities of developing a classification of esophagogastric junction tumors suitable for preoperative setting.
Lochman P
Bratisl Lek Listy; 2024; 125(2):96-101. PubMed ID: 38219062
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma of the stomach and esophagogastric junction with low DNA methylation show poor prognoses.
Urabe M; Matsusaka K; Ushiku T; Fukuyo M; Rahmutulla B; Yamashita H; Seto Y; Fukayama M; Kaneda A
Gastric Cancer; 2023 Jan; 26(1):95-107. PubMed ID: 36224483
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease.
Buas MF; Vaughan TL
Semin Radiat Oncol; 2013 Jan; 23(1):3-9. PubMed ID: 23207041
[TBL] [Abstract][Full Text] [Related]
12. Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma.
Nobel T; Molena D
Ann Gastroenterol Surg; 2019 Jul; 3(4):390-395. PubMed ID: 31346578
[TBL] [Abstract][Full Text] [Related]
13. Barrett esophagus: perspectives on its diagnosis and management in asian populations.
Amano Y; Kinoshita Y
Gastroenterol Hepatol (N Y); 2008 Jan; 4(1):45-53. PubMed ID: 22798736
[TBL] [Abstract][Full Text] [Related]
14. The Epidemiology of Esophageal Adenocarcinoma.
Coleman HG; Xie SH; Lagergren J
Gastroenterology; 2018 Jan; 154(2):390-405. PubMed ID: 28780073
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of esophageal adenocarcinoma in a rat surgical model by a cysteinyl leukotriene receptor‑1 antagonist.
Kohno T; Kinoshita J; Oyama K; Saito H; Shimada M; Tsuji T; Yamamoto D; Moriyama H; Inaki N; Ohta T
Oncol Lett; 2024 Apr; 27(4):147. PubMed ID: 38385106
[TBL] [Abstract][Full Text] [Related]
16. The antioxidant response in Barrett's tumorigenesis: A double-edged sword.
Peng D; Zaika A; Que J; El-Rifai W
Redox Biol; 2021 May; 41():101894. PubMed ID: 33621787
[TBL] [Abstract][Full Text] [Related]
17. RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
Lorenzen S; Biederstädt A; Ronellenfitsch U; Reißfelder C; Mönig S; Wenz F; Pauligk C; Walker M; Al-Batran SE; Haller B; Hofheinz RD
BMC Cancer; 2020 Sep; 20(1):886. PubMed ID: 32933498
[TBL] [Abstract][Full Text] [Related]
18. Short-term postoperative complications and prognostic factors in patients with adenocarcinoma of the esophagogastric junction.
Zhang H; Zhang W; Peng D; Zhu J
Thorac Cancer; 2018 Aug; 9(8):1018-1025. PubMed ID: 29927073
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of esophageal adenocarcinoma in a rat model by ursodeoxycholic acid.
Ojima E; Fujimura T; Oyama K; Tsukada T; Kinoshita J; Miyashita T; Tajima H; Fushida S; Harada S; Mukaisho K; Hattori T; Ohta T
Clin Exp Med; 2015 Aug; 15(3):343-50. PubMed ID: 25034655
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach.
Lou L; Wang Y; Cui J; Yan X; Xue L; Li Y
Tumour Biol; 2014 May; 35(5):5029-36. PubMed ID: 24488669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
